Recent Quotes (30 days)

You have no recent quotes
chg | %

LivaNova PLC  

(Public, LON:LIVN)   Watch this stock  
Find more results forLIVN
0.00 (0.00%)
Real-time:   2:31pm BST
LON real-time data - Disclaimer
Currency in USD
Range     -
52 week 41.21 - 63.00
Open     -
Vol / Avg. 0.00/1,769.00
Mkt cap 2,468.92M
P/E     -
Div/yield     -
EPS -1.29
Shares 48.18M
Beta     -
Inst. own 92%
Feb 20, 2017
Q4 2016 LivaNova PLC Earnings Release (Estimated)

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -8.55% -3.31%
Operating margin -11.73% -2.28%
EBITD margin - 12.55%
Return on average assets -4.40% -1.64%
Return on average equity -6.78% -3.57%
Employees 4,500 -
CDP Score - -


20 Eastbourne Terrace
United Kingdom - Map
+44-20-37865275 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.

Officers and directors

Damien McDonald Chief Executive Officer, Chief Operating Officer, Director
Age: 51
Vivid Sehgal Chief Financial Officer
Michel Darnaud President - Cardiac Surgery
Stefano Di Lullo President - Cardiac Rhythm Management
Jacques Gutedel President - Intercontinental
Age: 56
Rohan H. Hoare Ph.D. President - Neuromodulation
Age: 50
Brian Sheridan Senior Vice President, General Counsel, Company Secretary
David S. Wise Senior Vice President - Human Resources & Information Technology
Edward Andrle Senior Vice President - Strategy & Business Development
Pritpal Shinmar Senior Vice President - Global Market Access